Lang He
Papers
1
Total Citations
6
H-Index
1
About
Lang He is a pioneering researcher at the intersection of nanomedicine and precision therapeutics, with a primary focus on developing intelligent, feedback-regulated drug delivery systems for thrombolysis. His most notable contribution is the design of an artificial biomarker-based platform that addresses the critical clinical challenge of balancing recanalization efficacy with hemorrhagic risk in stroke treatment. By revealing the relationship between thrombus heterogeneity and thrombolysis resistance, He’s work enables personalized, real-time adjustment of thrombolytic therapy—a paradigm shift from the current body weight-based dosing strategies that often fail. His 2025 paper on this topic has already garnered 6 citations, signaling its immediate impact on the field. This achievement positions He as a leader in creating "smart" nanotherapeutics that adapt to patient-specific pathophysiology, promising safer and more effective interventions for thrombotic disorders. His research not only advances fundamental understanding of thrombus biology but also offers a tangible pathway toward clinical translation, making him a key figure to watch in precision nanomedicine.
Research Focus
Key Achievements
Top Papers
- 1